These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28160157)

  • 1. A comparison of serum miRNAs influencing metastatic growth of EMT6 vs 4THM tumor cells in wild-type and CD200R1KO mice.
    Gorczynski RM; Zhu F; Chen Z; Kos O; Khatri I
    Breast Cancer Res Treat; 2017 Apr; 162(2):255-266. PubMed ID: 28160157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
    Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
    PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor.
    Gorczynski RM; Erin N; Zhu F
    Cancer Med; 2016 Feb; 5(2):325-36. PubMed ID: 26725371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions.
    Gorczynski RM; Erin N; Maqbool T; Gorczynski CP; Gorczynski LY
    Breast Cancer; 2018 Sep; 25(5):547-559. PubMed ID: 29532324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling.
    Gorczynski RM; Chen Z; Khatri I; Podnos A; Yu K
    Breast Cancer Res Treat; 2013 Nov; 142(2):271-82. PubMed ID: 24166280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.
    Erin N; Podnos A; Tanriover G; Duymuş Ö; Cote E; Khatri I; Gorczynski RM
    Oncogene; 2015 Jul; 34(29):3860-70. PubMed ID: 25263452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6.
    Podnos A; Clark DA; Erin N; Yu K; Gorczynski RM
    Breast Cancer Res Treat; 2012 Nov; 136(1):117-27. PubMed ID: 23053647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.
    Curry A; Khatri I; Kos O; Zhu F; Gorczynski R
    PLoS One; 2017; 12(2):e0171586. PubMed ID: 28234914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
    Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF
    Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered gene expression in breast cancer liver metastases.
    Erin N; Wang N; Xin P; Bui V; Weisz J; Barkan GA; Zhao W; Shearer D; Clawson GA
    Int J Cancer; 2009 Apr; 124(7):1503-16. PubMed ID: 19117052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miRNAs as biomarkers of recurrent lung cancer.
    Munagala R; Aqil F; Gupta RC
    Tumour Biol; 2016 Aug; 37(8):10703-14. PubMed ID: 26867772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1.
    Erin N; Dilmaç S; Curry A; Duymuş Ö; Tanriover G; Prodeus A; Gariepy J; Gorczynski RM
    Cancer Immunol Immunother; 2020 Jan; 69(1):103-114. PubMed ID: 31811336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells.
    Dioufa N; Clark AM; Ma B; Beckwitt CH; Wells A
    Mol Cancer; 2017 Nov; 16(1):172. PubMed ID: 29137633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD200R2, anti-IL-9, anti-IL-35, or anti-TGF-β abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice.
    Gorczynski R; Yu K; Chen Z
    Transplantation; 2014 Jan; 97(1):39-46. PubMed ID: 24142033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice.
    Gorczynski RM; Clark DA; Erin N; Khatri I
    Breast Cancer Res Treat; 2011 Nov; 130(1):49-60. PubMed ID: 21165772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer.
    Bovy N; Blomme B; Frères P; Dederen S; Nivelles O; Lion M; Carnet O; Martial JA; Noël A; Thiry M; Jérusalem G; Josse C; Bours V; Tabruyn SP; Struman I
    Oncotarget; 2015 Apr; 6(12):10253-66. PubMed ID: 25860935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating exosomes potentiate tumor malignant properties in a mouse model of chronic sleep fragmentation.
    Khalyfa A; Almendros I; Gileles-Hillel A; Akbarpour M; Trzepizur W; Mokhlesi B; Huang L; Andrade J; Farré R; Gozal D
    Oncotarget; 2016 Aug; 7(34):54676-54690. PubMed ID: 27419627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.